Business
Why I’d buy today’s CSL share price over Mesoblast – Motley Fool Australia
Looking to invest in an ASX biotech? As a long-term investor, here’s why I would buy today’s CSL share price rather than Mesoblast.
The Mesoblast Limited(ASX: MSB) share price has been garnering a lot of attention recently. But here’s why I would buy today’s CSL Limited(ASX: CSL) share price over Mesoblast.
The Mesoblast share price has surged more than 126% in 2020. By contrast, the CSL share price remains relatively flat for the year. Despite the disparity in share price performance, I think that CSL provides greater potential for long-term investors.
CSL and COVID-19
In my opinion, CSL is one of the highest quality com…
-
Noosa News18 hours agoYoung voices shape Sunshine Coast’s future
-
Business18 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News16 hours agoAnother All-Star Cast, Another Tale of Family Chaos: The Trailer for Wes Anderson’s ‘The Phoenician Scheme’ Is Here
-
Business15 hours agoshould I buy hedged or unhedged ASX US-focused ETFs?